Search

1. Participants will be able to identify specific outcomes influencing the importance of early specialty palliative care referrals in patients with advanced hematologic malignancies. 2. Participants will be able to apply principles learned during the presentation to their own practice to improve delivery of palliative care to patients with advanced hematologic malignancies. Palliative care is underutilized in patients with advanced hematologic malignancies. These patients can experience significant physical and psychosocial symptoms due to illness and intensive treatments. This study evaluates the timing and impact of palliative care referrals on end-of-life outcomes to improve the utilization of palliative care in this population. Palliative care is an integrated part of standard oncology practice. Compared to patients with solid malignancies, less is known about the role of palliative care in patients with hematologic malignancies, leading to the underutilization of palliative care for this population. This study evaluates the timing of inpatient and palliative care referrals and the impact on end-of-life outcomes over a 5-year period to improve the utilization of palliative care in patients with advanced hematologic malignancies. This study compares end-of-life outcomes among patients who receive early specialty palliative care consults to those who receive late or no referral to palliative care. The primary outcome measure is hospitalization rates in the last 14 days of life. Secondary outcome measures include the documentation of advance care planning conversations and choices, in-hospital deaths, non-hospital deaths, hospice referrals, emergency room visits, intensive care unit admissions and disease-directed therapies in the last 14 days of life. This is a retrospective cohort of patients aged 18 and older with a diagnosis of acute leukemia, multiple myeloma with at least 4 lines of therapy, or high-risk lymphoma seen at an academic cancer center between July 1, 2018-June 30, 2023. Patients were separated into groups of early, late, or no specialty palliative care referrals. Kaplan Meier estimates and Cox proportional hazards regression models will be used to examine variables associated with timing of palliative care referral. Groups will be compared using the t-test, Mann-Whitney test, chi-square test or Fisher exact test depending on the examined variables. With approval, results will be available and presented at the conference. This study evaluates the timing of palliative care referrals and the impact on end-of-life outcomes over a 5-year period to improve the utilization of palliative care in patients with advanced hematologic malignancies. Disease specific management / Models of Palliative Care Delivery [ABSTRACT FROM AUTHOR]